← All diseases
Brain and nervous system
Progressive supranuclear palsy (PSP)
Would you like to receive a message when new research about Progressive Supranuclear Palsy (PSP) is available? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you'll find one sentence explaining what was studied — and you'll be notified as soon as there is new research on Progressive Supranuclear Palsy (PSP). View what Premium costs.
Publications (1027)
- Swallowing-related quality of life in progressive supranuclear palsy. (2026/05/06) ♡
- Frontotemporal dementia: does structural MRI-based clustering match clinical syndromes? (2026/05/05) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Progressive Supranuclear Palsy with Predominant Speech/Language Disorder. (2026/05/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Duloxetine for PSP-Related Speech Disorders. (2026/05/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Neurofilament light chain as a diagnostic and prognostic biomarker in atypical parkinsonisms: current evidence, new data, challenges, and future directions. (2026/05/01) ♡
- Between Habit and Mannerism: Idiosyncratic Motor Behavior. (2026/05/01) ♡
- Early Suspected Progressive Supranuclear Palsy-Cerebellar Type From MRI and Dopaminergic Imaging in a Patient Initially Presenting With Ataxia. (2026/05/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cognitive and behavioral disturbances in PSP and MSA: clinical features and imaging correlates. (2026/05/01) ♡
- Cognitive impairment on the Alzheimer's Disease Centers' Uniform Data Set Version 3 Neuropsychological Test Battery in a Peruvian population with progressive supranuclear palsy. (2026/05/01) ♡
- Procerus sign as a diagnostic clue for progressive supranuclear palsy. (2026/05/01) ♡
- Cytoskeletal Imbalance and Axonal Vulnerability in Sporadic PSP-RS: Early Changes in a Human iPSC-Derived Neuronal Model with Altered mTOR Signaling. (2026/04/23) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Possible Significance of Proteomics in Understanding Molecular Mechanisms of Progressive Supranuclear Palsy, Corticobasal Degeneration, Multiple System Atrophy, and Dementia with Lewy Bodies. (2026/04/23) ♡
- A Short Version of Carers' Quality of Life Questionnaire for Parkinsonism: Data from Progressive Supranuclear Palsy Network. (2026/04/01) ♡
- Deep Learning-Based Brainstem Segmentation and Multi-Class Classification for Parkinsonian Syndrome. (2026/04/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Praja1 E3 ubiquitin ligase and the role it plays in neurodegeneration. (2026/04/01) ♡
- Distinctive magnetic resonance imaging features of progressive supranuclear palsy with cerebellar phenotype: hummingbird and Mickey Mouse signs. (2026/03/04) ♡
- A Hierarchical Etched Grid for Correlative Chemical Imaging. (2026/03/04) ♡
- 18 F-FDG, 18 F-FP-CIT, and 18 F-Florzolotau PET Imaging in Progressive Supranuclear Palsy : Region-Specific Correlations Between Glucose Metabolism, Dopaminergic Function, and Tau Pathology. (2026/03/01) ♡
- Utility of Locus Coeruleus Signal Intensity on High-resolution T1-weighted MR Imaging with Magnetization Transfer for Differentiating Parkinson's Disease from Atypical Parkinsonism. (2026/02/26) ♡
- Visual interpretation of [(18)F]Florzolotau Tau-PET imaging for differentiating Alzheimer's disease and progressive supranuclear palsy. (2026/02/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Comparing and combining TSPO-PET tracers in tauopathies. (2026/02/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Barcelona Progressive Supranuclear Palsy (PSP) Registry: Clinical, Oculomotor, and Cerebrospinal Fluid Markers; from Suggestive to Definite Cases. (2026/02/01) ♡
- Spatial Metabolic Covariance Networks in Progressive Supranuclear Palsy: Implications for Symptomatology and Their Neural Basis. (2026/02/01) ♡
- Hybrid Tau-PET/MRI study: Quantitative susceptibility mapping in progressive supranuclear palsy and its correlation with Tau-PET. (2026/02/01) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Safety, Tolerability, Pharmacokinetics, and Brain Target Occupancy of the OGA Inhibitor ASN90 in Healthy Participants. (2026/02/01) ♡
- Backward walking as a mobility assessment and exercise intervention for persons with neurologic disorders: A scoping review. (2026/02/01) ♡
- White matter hyperintensities in the deep cerebral venous territory differ between subcortical and cortical 4-repeat tauopathies. (2026/02/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Percutaneous endoscopic gastrostomy in atypical parkinsonian syndromes: survival and aspiration outcomes from a retrospective international cohort. (2026/01/30) ♡
- Plasma pTau217 and Neurofilament Light Chain as Differentiative Markers for Progressive Supranuclear Palsy From Parkinson Disease. (2026/01/13) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Rapidly progressive dysphagia and vertical supranuclear gaze palsy: a key diagnostic clue for progressive supranuclear palsy in Levodopa-Resistant parkinsonism. (2026/01/13) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Wernicke's encephalopathy unmasking progressive supranuclear palsy and Alzheimer's pathology: a diagnostic challenge in an older adult. (2026/01/06) ♡
- A Biomarker-Based Classification of Corticobasal Syndrome. (2026/01/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Absence of STN Neuronal Activity during MER in DBS Surgery: Diagnostic and Clinical Implications. (2026/01/01) ♡
- A Mathematical Model of Cellular Aggregation Predicts Patterns of Tau Accumulation in Neurodegenerative Disease. (2026/01/01) ♡
- Proximity Labeling of the Tau Repeat Domain Enriches RNA-Binding Proteins That Are Altered in Alzheimer's Disease and Related Tauopathies. (2026/01/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Utility of Progression Rate Since Symptom Onset in Predicting Subsequent Survival in Progressive Supranuclear Palsy. (2026/01/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Reply to: Utility of Progression Rate Since Symptom Onset in Predicting Subsequent Survival in Progressive Supranuclear Palsy. (2026/01/01) ♡
- Interpeduncular Angle: A Possible Marker to Differentiate Atypical Parkinsonism from Idiopathic Parkinson's Disease. (2026/01/01) ♡
- ERBB4 colocalizes with phosphorylated tau aggregates in multiple tauopathies. (2026/01/01) ♡
- Progressive Supranuclear Palsy or Something More? Unveiling Late-Onset Wilson's Disease. (2026/01/01) ♡
- Comparative [18F]Florzolotau and [18F]FDG PET Imaging Patterns in Anti-IgLON5 Disease and Progressive Supranuclear Palsy. (2026/01/01) ♡
- PET evaluation of cholinergic system differences in progressive supranuclear palsy and age-matched controls using [(18)F]VAT. (2026/01/01) ♡
- 4R-tau seeding activity reveals molecular subtypes in progressive supranuclear palsy. (2025/12/31) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Plasma NFL, GFAP, sTREM2, pTau231, and clinical severity in progressive supranuclear palsy. (2025/12/26) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Paraneoplastic progressive supranuclear palsy: a case report and literature review. (2025/12/26) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. The Role of MRI in Capturing Phenotypic Variability in Progressive Supranuclear Palsy: Lessons for Future Clinical Trials. (2025/12/23) ♡
- Patterns of Longitudinal Regional Brain Atrophy in Patients With Different Progressive Supranuclear Palsy Clinical Variants. (2025/12/23) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Progressive Supranuclear Palsy With Post-traumatic Frontal Lobe Damage Mimicking Anti-IgLON5 Antibody Disease. (2025/12/22) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Diagnostic utility of biomarkers in progressive supranuclear palsy: toward a biotyping framework. (2025/12/17) ♡
- Inflammatory and Neurotrophic Factors and Their Connection to Quality of Life in Progressive Supranuclear Palsy-Single-Center Study. (2025/12/17) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.